Trial Profile
A Study of Endostar in Combination With Chemotherapy Followed by Endostar Maintenance Therapy in Patients With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Simcere Pharmaceutical Group
- 01 Mar 2017 New trial record